For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Vaccine makers will have to run large new trials before updated shots can be approved for everyone who is not at a higher-than-average risk.

Pediatricians should provide teens with their contraceptive of choice on the same day as counseling, in the absence of medical contraindications.

Between 2012 and 2022, incidence rates of breast cancer increased by 1% per year in women older than 50 years and by 1.4% in women younger than 50 years.

We want you to take advantage of everything Clinical Advisor has to offer. To view unlimited content, log in or register for free.